Skip to main content
Publications
Anthony MS , Djebarri L, Beachler DC, Aroda VR, Calingaert B , Pan C, Crowe C, Lanes S, Rothman KJ , Saltus CW , Berreghis S, Parlett LE, Bocage C, Walsh KE, Juhaeri J, Johannes C . Risk of anaphylaxis among new users of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) . Poster presented at the American Diabetes Association's 83rd Scientific Sessions; June 23, 2023. San Diego, CA. [abstract] Diabetes. 2023 Jun 20; 72(supplement_1):846-P. doi: 10.2337/db23-846-P
Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS , Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk . J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043
Smit LA, Kogevinas M, Anto JM, Bouzigon E, Gonzalez JR, Le Moual N, Kromhout H, Carsin AE , Pin I, Jarvis D, Vermeulen R, Janson C, Heinrich J, Gut I, Lathrop M, Valverde MA, Demenais F, Kauffmann F. Transient receptor potential genes, smoking, occupational exposures and cough in adults . Resp Res. 2012 Mar 23;13(1):26. doi: 10.1186/1465-9921-13-26